The United States Patent and Trademark Office (USPTO) has issued patent US12582593B2 to The Procter & Gamble Company. This patent covers novel oral care compositions containing specific ingredients such as retinoid compounds, amino acids (like palmitoyl KTTKS), and/or olive oil. The claimed inventions are intended for use in preventing, stopping, or reversing gingival recession, enhancing gum barrier protection, promoting collagen and fibrillin synthesis, and increasing gum resilience and epidermal thickness.

This patent grant signifies a new intellectual property asset for The Procter & Gamble Company in the oral care sector. While patents do not impose direct regulatory obligations on other entities, they establish exclusive rights for the patent holder. Companies operating in the pharmaceutical or oral care manufacturing space, particularly those developing products for gum health, should be aware of this granted patent to ensure their own product development and marketing do not infringe upon these exclusive rights. No immediate compliance actions are required for other entities, but awareness is key for competitive and legal positioning.